España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Lucid Diagnostics
LUCD
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.9579
0.03
3.68%
At close: -
$0.9615
0.00360
0.38%
After Hours: 7:57 PM EDT
Get Report
Comment
Lucid Diagnostics (LUCD) Forecast
News
Earnings
Lucid Diagnostics (LUCD) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Lucid Diagnostics (NASDAQ:LUCD) Stock
Lucid Diagnostics Stock (NASDAQ: LUCD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, December 23, 2024
Lucid Diagnostics Granted 180-Day Extension B...
Benzinga Newsdesk
Thursday, December 19, 2024
Lucid Diagnostics Partners With VITALExam To ...
Benzinga Newsdesk
Lucid Diagnostics Partners With VITALExam, To...
Benzinga Newsdesk
Wednesday, December 11, 2024
Lucid Diagnostics' EsoGuard DNA Test Study Ac...
Benzinga Newsdesk
Monday, December 09, 2024
Tesla To $370? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
Ascendiant Capital Maintains Buy on Lucid Dia...
Benzinga Newsdesk
Tuesday, December 03, 2024
Lucid Diagnostics Completes $21.95M Convertib...
Benzinga Newsdesk
Wednesday, November 20, 2024
Lucid Diagnostics And Subsidiary Of PAVmed An...
Benzinga Newsdesk
Friday, November 15, 2024
Cantor Fitzgerald Maintains Overweight on Luc...
Benzinga Newsdesk
Thursday, November 14, 2024
Canaccord Genuity Maintains Buy on Lucid Diag...
Benzinga Newsdesk
Needham Reiterates Buy on Lucid Diagnostics, ...
Benzinga Newsdesk
Wednesday, November 13, 2024
Lucid Diagnostics Q3 2024 GAAP EPS $(0.25) Mi...
Benzinga Newsdesk
Earnings Scheduled For November 13, 2024
Benzinga Insights
Tuesday, November 12, 2024
A Glimpse of Lucid Diagnostics's Earnings Potential
Benzinga Insights
Thursday, November 07, 2024
Lucid Diagnostics shares are trading higher a...
Benzinga Newsdesk
Lucid Diagnostics' ESOGUARD BE-1 Clinical Val...
Benzinga Newsdesk
Tuesday, November 05, 2024
Lucid Diagnostics Expands Direct Contracting ...
Benzinga Newsdesk
Tuesday, October 15, 2024
Lucid Diagnostics Receives Notice Of Allowanc...
Benzinga Newsdesk
Wednesday, October 09, 2024
October's 4 Best Penny Stocks: High-Risk, High-Reward Picks
MarketBeat
Tuesday, October 08, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Monday, September 16, 2024
PAVmed Announces Efforts To Regain Nasdaq Com...
Benzinga Newsdesk
Tuesday, September 10, 2024
Ascendiant Capital Maintains Buy on Lucid Dia...
Benzinga Newsdesk
Tuesday, September 03, 2024
Lucid Diagnostics And Front Line Mobile Healt...
Benzinga Newsdesk
Tuesday, August 20, 2024
Lucid Diagnostics shares are trading lower af...
Benzinga Newsdesk
Lucid Diagnostics Announces Publication Of An...
Benzinga Newsdesk
Tuesday, August 13, 2024
Canaccord Genuity Maintains Buy on Lucid Diag...
Benzinga Newsdesk
Lucid Diagnostics Announced That The American...
Benzinga Newsdesk
Needham Reiterates Buy on Lucid Diagnostics, ...
Benzinga Newsdesk
Monday, August 12, 2024
Lucid Diagnostics Q2 2024 Adj EPS $(0.20) Bea...
Benzinga Newsdesk
Tuesday, August 06, 2024
Lucid Diagnostics Announces New Real-World Da...
Benzinga Newsdesk
Tuesday, July 23, 2024
Lucid Diagnostics Reports 31% Increase In Qua...
Benzinga Newsdesk
Tuesday, July 02, 2024
Lucid Diagnostics shares are trading higher a...
Benzinga Newsdesk
Lucid Diagnostics Announces Data From ESOGUAR...
Benzinga Newsdesk
Wednesday, June 12, 2024
Lucid Diagnostic Reports 4,000 Firefighter Un...
Benzinga Newsdesk
Thursday, June 06, 2024
Ascendiant Capital Maintains Buy on Lucid Dia...
Benzinga Newsdesk
Wednesday, May 15, 2024
Cantor Fitzgerald Reiterates Overweight on Lu...
Benzinga Newsdesk
Monday, May 13, 2024
Needham Reiterates Buy on Lucid Diagnostics, ...
Benzinga Newsdesk
Lucid's Chairman And CEO Says We Strengthened...
Benzinga Newsdesk
Lucid Diagnostics Q1 2024 Adj EPS $(0.21) Bea...
Benzinga Newsdesk
Thursday, May 09, 2024
Lucid Diagnostics Says EsophaCap Device Recal...
Benzinga Newsdesk
Thursday, May 02, 2024
Lucid Diagnostics Announces Peer-Reviewed Pub...
Benzinga Newsdesk
Tuesday, April 30, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Monday, April 29, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Friday, April 12, 2024
Needham Reiterates Buy on Lucid Diagnostics, ...
Benzinga Newsdesk
Wednesday, March 27, 2024
Cantor Fitzgerald Maintains Overweight on Luc...
Benzinga Newsdesk
Needham Reiterates Buy on Lucid Diagnostics, ...
Benzinga Newsdesk
Monday, March 25, 2024
Lucid Diagnostics Q4 EPS $(0.23) Beats $(0.26) Estimate, Sales $1.04M Miss $1.05M Estimate
Happy Mohamed
Lucid Diagnostics Provides Business Update; R...
Benzinga Newsdesk
Earnings Scheduled For March 25, 2024
Benzinga Insights
Friday, March 22, 2024
Earnings Preview: Lucid Diagnostics
Benzinga Insights
Show More
